We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01129544
Recruitment Status : Active, not recruiting
First Posted : May 24, 2010
Last Update Posted : January 2, 2018
Boston Children’s Hospital
Children's Hospital Medical Center, Cincinnati
University of California, Los Angeles
Information provided by (Responsible Party):
David Williams, Boston Children's Hospital